Reduction of anthracycline-induced cardiotoxicity
US5744455A · kind A · utility
2Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 1993 |
| Grant date | Apr 28, 1998 |
| Priority date | — |
| Expiry date | Sep 3, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for preventing cardiotoxicity in a human in need of such preventive treatment, the method including administering an effective amount of a bisdioxopiperazine. Also disclosed is a method for preventing cardiotoxicity induced by the administration of an anthracycline. Further, a tumoricidal, cardioprotective combination of agents is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.